泰德医药（浙江）股份有限公司（股票代码：03880）于2026年7月6日披露2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司总股本保持为141,800,000股（每股面值人民币1元），与上月持平。公司已发行H股全部在香港联合交易所上市，未设任何库存股份。
公告显示，报告期内，公司并无新增发行、购回、注销或库藏股活动。同时，公司并未授予或行使任何股权激励计划或股份期权。此外，公告确认公司目前持有足够的公众持股量，符合香港联合交易所《上市规则》以及相关法律法规有关最低公众持股量的要求。
公司表示将继续严格遵守香港联合交易所的上市规则和相关法律法规，加强公司治理和信息披露。本次公告由联席公司秘书吴东澄签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.